3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
81
Breast Neoplasms
10
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
4
Bulbo-Spinal Atrophy, X-Linked
4
Neoplasms
3
Salivary Gland Neoplasms
2
Osteoporosis
2
Thrombocytosis
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Stage I Prostate Adenocarcinoma
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Prostate Adenocarcinoma
1
Primary Myelofibrosis
1
Primary Dysautonomias
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Castrate Metastatic Prostate Cancer
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metabolic Diseases
1
Interventions
Metformin
139
Clomiphene
44
Letrozole
36
Inositol
28
Folic Acid
17
Exercise
17
Progesterone
16
Ethinyl Estradiol
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Chorionic Gonadotropin
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
8
Diet
8
Cholecalciferol
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Menotropins
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycystic Ovary Syndrome
×
bicalutamide
×
Clear all
NCT05647356
2022-12-12
REFUEL PCOS
Royal College of Surgeons, Ireland
Phase NA
Unknown
16 enrolled